Dynemicin A is a recently identified antitumor antibiotic. Upon activation, dynemicin is reported to cause double-stranded cleavage of DNA, putatively through the intermediacy of a diradical. Computer modeling of this activation and cleavage process is described herein as part of an effort to establish a structural hypothesis for this mechanistic sequence and for the design of simple analogues. Intercalation complexes of duplex dodecamers [d(CGCGAATTCGCG)J2
The cleavage of DNA is a key process in the transfer of genetic information, the mode of action of certain chemotherapeutic agents, and the function of reagents designed for DNA modification and structure determination. DNA cleavage can be effected with a variety of agents ranging from the simple hydroxyl radical to relatively complex restriction enzymes. Within the past 5 years, the antitumor antibiotics calicheamicin (1), esperamicin (2) , and neocarzinostatin (3) have emerged as a new structural and mechanistic class of DNA-cleaving agents that are proposed to operate through the inducible generation ofan arenyl or indenyl diradical. The most recently identified member of this class is dynemicin A (structure 1 in Scheme I), a compound that exhibits potent cytotoxicity and in vivo antitumor activity (4, 5) . Dynemicin has been shown to interact with the minor groove of DNA and, upon activation, to cause double-strand breaks 3 base pairs (bp) apart (6) . Examination of the structure of dynemicin suggests that it could be activated for DNA cleavage through reduction of its anthraquinone subunit, resulting in heterolysis of the adjacent epoxide ring. Addition of a nucleophile to, or protonation of, the resultant anthraquinone methide (structure 2 in Scheme I) would provide an activated derivative 3 which, in the absence of the constraints imposed by the original epoxide ring, would undergo facile cycloaromatization to diradical 4 (Scheme I). [Heats of formation were determined by using the AMPAC program (QCPE no. 506, version 2.1) with the AM1 Hamiltonian (7) .] Abstraction of proximate deoxyribosyl hydrogens by this diradical would initiate oxidative cleavage on opposing DNA strands. Conversion of diradical 4 to the alternative ene-diyne structure 7 is not observed.
Semiempirical (8) and molecular mechanics (9) studies on dynemicin itself have provided valuable information in support of the above mechanism. Thus far, however, computational methods have not been used to evaluate the role of DNA in the mode of action of dynemicin, although they have been applied to calicheamicin (10) and neocarzinostatin (11) , yielding models that are consistent with known DNA cleavage patterns. We describe herein computer modeling studies designed to delineate at the molecular level the interaction of dynemicin and dynemicin-derived intermediates with oligonucleotides selected to emulate native DNA. These studies address several fundamental issues that are crucial to the development of a structural hypothesis for the mode of action of dynemicin and its analogues, including (i) the mechanistic fate of the two possible enantiomers of dynemicin [structures 1-(2R) or 1-(2S)], a point of much interest since the absolute stereochemistry of dynemicin is as yet unknown, (ii) the effect of nucleophile size and approach trajectory in the activation step and the dynamics of this activation process, (iii) the influence of oligonucleotide sequence and length on dynemicin intercalation and activation, and (iv) the relationship of intercalation sites to cleavage sites. The answers to these questions provide a structural basis for evaluating mechanistic proposals, for predicting DNA cleavage patterns, and for designing new cleaving agents based on the dynemicin lead. AMBER did not extend to acetylenes, it was necessary to introduce standard parameters from MM2 into AMBER. In the case of stretching interactions, this was done by multiplying the MM2 constant by a proportionality factor; with other parameters it was possible to use them without modification, or to use values for available substructures in AMBER which had force constants in MM2 identical to those of acetylenes. The resulting modified AMBER force field gave structures that were identical to those obtained with MM2 and, for dynemicin A itself, produced a structure consistent with the x-ray crystallographic structure (5) . (Copies of the modified parameters used in these calculations are available from the authors upon request.)
METHODS
Initial intercalation spaces in the duplex oligonucleotides were formed by docking only the anthraquinone portion of dynemicin into position between base pairs and minimizing for 1000 iterations under AMBER. The intercalator was then removed, and the molecule of interest was placed into the gap. The entire structure was then minimized to a gradient of <0.200 kJ/mol per A by using the modified force field. Structures used to study the effect of nucleophile size on DNA structure and strain energy were generated by adding a hydrogen at C8 of 2 in the minimized complex, rearranging the bond orders to give an unminimized form of 3, and carrying out a substructure minimization on C8 to permit that atom to pyramidalize. This yielded a complex designed to mimic the conditions that would exist immediately after addition of a nucleophile. The hydrogen at C8 was then replaced by a methyl, ethyl, isopropyl, or tert-butyl group. Each complex was then minimized as described above, and the strain energy was calculated.
Minor groove widths were determined by measuring the perpendicular distance between the centers of mass of phosphorus atoms on complementary strands and subtracting 5.8 A, the Van der Waals diameter of a phosphate group (15 where the N-lone pair distance was set to 0.600 A, the value given in the MM2 force field (13, 14) . Molecular dynamics simulations were carried out by using the minimized complexes of 5-(2R) and 5-(2S) with [d(CGC-GAATTCGCG)h2 as starting structures. Bonds to hydrogen were constrained with the SHAKE algorithm (16) , and the thermal stability of each system was maintained by coupling to a 300 K external bath (17) . Following a 15-ps preequilibration, the complexes were observed for 30 ps. A timestep of 1 fs was used during both the preequilibration and observation periods, and the nonbonded interaction array was updated every 0.5 ps.
RESULTS
Because of the absence of DNA cleavage data at the outset of this study, G+ C-and A+T-rich oligonucleotide sequences were selected to explore two generic intercalation sites. Sequence selection around these sites was guided by symmetry considerations (to simplify calculations) and/or by the availability of solid state (18) or solution phase (19) (20) (21) (22) (23) (24) structural information (for calibration). Sequence length was initially set at 8 bp to minimize computational time. However, an early finding of this study was that the intercalation complexes of the resultant duplex octamers exhibit disrupted base pairing at terminal residues when full, rather than substructure, minimizations were conducted. Since this modeling suggested, in agreement with solution studies of DNA intercalation complexes, that the effects of intercalation are transmitted more than four residues in both directions from the site of intercalation, the oligonucleotide length was extended to duplex dodecamers. The resultant duplex structure for uncomplexed [d(CGCGAATTCGCG)h2 was found to differ only slightly from the x-ray crystal structure (18) , the latter being slightly more tightly wound as a result of crystalpacking forces. Intercalation complexes of both duplex dode-camers produced a DNA model that displayed normal end group base pairing.
Since the absolute stereochemistry of dynemicin has not been established, intercalation complexes were constructed of the aforementioned duplex dodecamers with both possible enantiomers of dynemicin and of the resultant quinone methide, cyclization precursor, and pyrazine surrogate for the diradical. All minimized duplexes were found to be in the right-handed, Watson-Crick B form, with most of the sugar ring puckers C2'-endo. The overall structure of the oligonucleotides in the complexes was little changed from the uncomplexed form. Separation of the base pairs immediately above and below the intercalation site increased from 3.4 A to 6.4-6.6 A upon intercalation of dynemicin, and Watson-Crick base pairing remained intact. The intercalation site was wedgeshaped, similar to that observed for a nogalamycinoligonucleotide complex (25) and a daunomycin-oligonucleotide complex (26) . Base pairs directly adjacent to the intercalation site exhibited a slight propellor twist and were buckled. The anthraquinone moiety was puckered and not planar. Although this puckering is not observed in the daunomycin complex, it is seen in nogalamycin, which, like dynemicin, has an aliphatic ring rigidly attached to the intercalator subunit (25) . Two general energy minima were found for the complexes, one with the anthraquinone intercalated more deeply and the ene-diyne moiety closer to the double-helical axis than in the other. The proposed explanation for this is that H5' and/or H4' of base 8 cause unfavorable Van der Waals interactions when they are in the same plane as the ene-diyne (or diradical surrogate) portion. This results in a local minimum when the ene-diyne/diradical surrogate is inserted beyond these hydrogens. Although the size of the barrier between these two minima is unknown, experimental data available for the structurally related daunomycin-oligonucleotide complex, in which the amino sugar lies on the floor of the minor groove and the D ring protrudes into solution from the major groove, suggests that deeply intercalated species are energetically accessible. This also suggests that intercalation depth may be an important structural parameter in the design of analogues for abstraction of specific hydrogens.
Comparison ofthese complexes provides an understanding of the structural changes that attend the activation and cyclization steps, including the differing roles of the two possible dynemicin enantiomers. Specifically, for the conversion of the (2S)-dynemicin complex (Fig. 1 Left) 2 Left and 3 Left), atoms C23-C28 move in a clockwise sense with respect to the pseudo-plane ofthe intercalated anthraquinone subunit, resulting in a structure in which these atoms are aligned along the minor groove. The initial alignment of the (2R)-dynemicin complex (Fig. 1 Right) is similar to that found for the (2S) complex. However, as expected from the contrasting handedness of the (2R)-dynemicin isomer, its conversion to the (2R)-diyl surrogate proceeds with the counterclockwise movement of atoms C23-C28 with respect to the intercalated anthraquinone subunit, producing a structure in which these atoms align across the minor groove (Figs. 2 Right and 3 Right).
Although alignment of the intercalating species along or across the minor groove does not by itself determine whether the resultant diyl could cleave DNA, it does determine access to and steric encumbrance, at least for nucleophilic attack, at the site of attachment for the incoming nucleophile or proton source. This is clearly seen for the (2S) derivatives, where the trajectory of nucleophilic attack or protonation would be easily accommodated along the minor groove, while the path for the (2R) derivatives would encounter severe steric en- cumbrance from the 3'-5' strand of the oligonucleotide. This trend is further supported by the relative stabilities of the activated complexes: in all cases, the (2S) complex is more stable than the (2R) complex, with energy differences ranging from 8.82 kcal/mol for nucleophiles similar to a methyl group in size to 14.72 kcal/mol for a tert-butyl group. For an activation process involving protonation of an anthraquinone methide, the product complexes are of comparable energy, suggesting that either could be accommodated in the minor groove. However, protonation of the (2R)-anthraquinone subunit would preferentially occur prior to association with DNA, since direct protonation of the anthraquinone subunit when complexed with DNA would be sterically disfavored. Alternatively, a relay proton transfer mechanism could be involved, in which case a small proton transfer agent (e.g., water) could associate with DNA prior to the intercalation of dynemicin and might remain present in the minor groove so as to allow direct contact with dynemicin. An analysis of distances between abstractable hydrogens on the sugar-phosphate backbone and radical centers on 4 (Fig. 4) . None of the bases ofthe 3'-5' strand come within abstraction distance of the 5-(2R)-"diyl" during the simulation, the closest being (Fig. 5) . It has been observed (15) in x-ray diffraction studies on DNA fibers that the minor groove width of B-DNA increases with the proportion of G-C base pairs, and it is probable that the larger minor groove width of the GC dodecamer permits intercalation with less distortion.
CONCLUSION
Sixteen intercalation complexes ofboth possible enantiomers of dynemicin and of dynemicin-derived intermediates with duplex octamers and dodecamers were constructed and minimized. While the duplex octamer complexes suffered from disrupted base pairing at the termini, complexes with duplex dodecamers exhibited normal end group base-pairing. This suggests that duplex octamers may not be a reliable model for DNA in dynemicin-oligonucleotide complexes, and longer oligonucleotides should be used. Both enantiomers of dynemicin and putative precyclization intermediates yield intercalation complexes with similar orientations of the ene-diyne within the minor groove of DNA. Upon examination of the trajectory of attack of a nucleophile to the quinone methide intermediate, however, differences between the two enantiomers become apparent. The approach of a nucleophile to either enantiomer is hindered by the 3'-5' strand of DNA, and the effect is greater for the (2R) enantiomer. In addition to this kinetic effect on activation, it is also found that the activated (25) complex is lower in energy than the (2R) complex for various nucleophiles. Cyclization to the diyl intermediate results in a rotation of the diyl moiety with respect to the intercalation plane, improving the alignment of the (2S) enantiomer within the minor groove, while causing the (2R) enantiomer to become aligned across the minor groove. Although it is not yet known whether dynemicin intercalates before or after activation occurs, the above evidence suggests that if intercalation occurs first, the (2S) enantiomer of dynemicin is better suited for nucleophilic activation within the complex and also indicates that any nucleophile attacking at C8 of the quinone methide intermediate must be small.
In all complexes, the diyl is much closer to the 5'-3' strand of the oligonucleotide than to the 3'-5' strand. Even so, significant motion of the intermediate within the intercalation complex would be expected to occur, permitting abstraction from the 3'-5' strand. Molecular dynamics simulations designed to address this issue suggest that, although motion within the intercalation site brings the 5-(2S)-diyl surrogate within abstraction distance of both strands of DNA, abstraction from the 3'-5' strand would necessarily follow abstraction from the 5'-3' strand for the complex with 4-(2R).
